Multiple Immunodiagnostic Kit and its Uses

The multiple immunodiagnostic kit using IgY antibodies from immunized hen eggs addresses the need for rapid and cost-effective detection of bacterial pathogens in aquatic organisms, offering simultaneous and accurate results without specialized equipment or training.

BR102017008736B1Active Publication Date: 2026-11-10UNIV EHSTADUAL PAULISTA KHULIO DE MESKITA FILO UNESP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR102017008736
Authority / Receiving Office
BR · BR
Patent Type
Patents
Current Assignee / Owner
Filing Date
2017-04-26
Publication Date
2026-11-10
Estimated Expiration
2037-04-26

AI Technical Summary

Technical Problem

Current microbiological diagnostic methods for bacterial infections in aquatic organisms require specialized equipment, trained personnel, and laboratory infrastructure, leading to high costs and prolonged processing times, and there is a need for a cost-effective, rapid, and accurate diagnostic tool for multiple bacterial pathogens.

Method used

A multiple immunodiagnostic kit using a lateral flow immunoassay with monospecific IgY antibodies extracted from immunized hen eggs, allowing simultaneous detection of Aeromonas hydrophila, Streptococcus agalactiae, and Flavobacterium columnare without specialized equipment or training, utilizing an integrated structure with immunochromatographic strips and glass fiber elements.

Benefits of technology

Enables rapid, accurate, and cost-effective simultaneous detection of multiple bacterial pathogens in a single sample, reducing the need for specialized equipment and training, and providing immediate results with high sensitivity and specificity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000019_0000
    Figure 00000019_0000
  • Figure 00000019_0001
    Figure 00000019_0001
  • Figure 00000019_0002
    Figure 00000019_0002
Patent Text Reader

Abstract

Multiple immunodiagnostic kit and uses thereof. The present invention relates to a multiple immunodiagnostic kit for the simultaneous detection, in a single sampling, of biological and non-biological molecules and antigens constituting the cell wall of bacterial cells of the genera and species: Streptococcus agalactiae; Lactococcus garvieae; Aeromonas hydrophila and Flavobacterium columnare and their respective exotoxins. The kit comprises two circular platforms, upper and lower, both made of recycled plastic, for example, polyethylene terephthalate. Detection is carried out by means of monospecific antibodies of the IgY class extracted from the yolk of previously stimulated laying hens with homologous bacterial antigens and applied in the immunochromatographic assay.
Need to check novelty before this filing date? Find Prior Art

Description

1 / 15 MULTIPLE IMMUNODIAGNOSTIC KIT AND USES IN THE SAME FIELD AS THE INVENTION

[01] The present invention is situated within the fields of Applied Immunology, Microbiology, Preventive Veterinary Medicine and Aquaculture, specifically in the area of ​​immunochemistry applied to the immunodiagnosis of bacterial diseases affecting aquatic organisms. The invention describes a multiple immunodiagnostic kit using a lateral flow immunoassay, consisting of an integrated structure formed by two circular platforms, upper and lower, equipped with a central region for sample application and distribution in communication with immunochromatographic strips intended for the rapid and simultaneous detection of the pathogens Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae and Flavobacterium columnare. Detection is performed using monospecific antibodies of the IgY class, extracted and purified from the yolk of eggs from laying hens previously immunized with the respective bacterial antigens. FUNDAMENTALS OF THE INVENTION

[02] The technology is primarily based on the multiple detection of molecules on a large scale, and can be applied to analyze molecules such as toxins or drugs, diagnose organic or pathological disorders. Both applications have the potential for multiple diagnoses.

[03] Infection of aquatic organisms by pathogenic bacteria generates significant economic impacts on global fish farming. Among the main infecting microorganisms are: Aeromonas hydrophila, Petition 870260077127, dated 03 / 08 / 2026, page 8 / 29 2 / 15 Streptococcus agalactiae, Lactococcus garvieae, and Flavobacterium columnare. Accurate diagnosis of these diseases, through identification of the etiological agent, is essential for the choice and effectiveness of clinical treatment, and can ultimately prevent the misuse of drugs, especially antibiotics that are not effective against certain microbial genera and species, resulting in therapy failure and the development of microbial resistance.

[04] Microbiological diagnostic methods through cultivation, isolation and identification by biochemical kits or molecular tools such as Polymerase Chain Reaction (PCR), although sensitive and specific, require the use of equipment, laboratory structure adapted to biosafety regulations and specialized technical training, adding increased costs and time for sample processing and obtaining results.

[05] Therefore, the technology presented in the present invention makes it possible to develop a multiple immunodiagnostic kit capable of simultaneously detecting the four aforementioned bacterial diseases in a single sample, without the need for specialized equipment, laboratories or technical training, and with low production cost, and with high economic and functional viability. STATE OF THE ART

[06] The prior art search found the following documents considered relevant to the present invention: BR102014004679A2, BR102014008162; PI0805991-8A2; PI0104180-0A2 and PI9301103-2 A2. Although they have functional characteristics similar to those used in the present application, since they are methods of Petition 870260077127, dated 03 / 08 / 2026, page 9 / 29 3 / 15 immunodiagnostic and molecular methods, therefore governed by the laws of immunochemistry and molecular mechanisms, do not present structural, geometric or industrial similarity to the proposed kit. Furthermore, these documents do not present functional similarities, since the kit proposed in the present invention differs due to its functional structure which enables it to capture the sample in a single well and distinguish diverse species of microorganisms, antigens, toxins or biological molecules.

[07] Document BR102014004679 A2 describes an immunodiagnostic test containing four specific biomarkers for the detection of the causative agents of bacterial and viral meningitis in humans. However, the prototype and functionality are distinct, showing no similarity, with the kit proposed in the present invention. Furthermore, the test described in that document is distinct both structurally and functionally, since it does not use IgY antibodies as biomarkers, and because it obtains specificity for other microorganisms.

[08] Documents BR102014008162 and PI0805991-8 A2 describes identification methods, both by polymerase chain reaction (PCR), differing from the technology proposed in the present invention by requiring appropriate laboratory infrastructure, equipment, and a technologist to perform and interpret the results. Additionally, they require a longer time period to obtain results, generating a higher cost for outsourcing compared to the technology proposed in the present invention. In contrast, the present invention is for immediate use and can be performed without the need for infrastructure, equipment, or a technologist, with immediate results, low production costs, and high accuracy. (Petition 870260077127, dated 03 / 08 / 2026, page 10 / 29) 4 / 15 specificity and sensitivity for detecting pathogens and biological molecules.

[09] Finally, documents PI0104180-0 A2 and PI9301103-2 A2 are based on the production and purification of bacterial and viral antigens respectively and used as signaling molecules in immunological assays, or as specific antigens for vaccine production. Therefore, these documents do not present any conflict with the present invention, either structurally or functionally. BRIEF DESCRIPTION OF THE INVENTION

[10] The present invention aims to provide a multiple immunodiagnostic kit by lateral flow immunoassay, intended for the rapid and simultaneous detection, in a single sample, of specific bacterial antigens of Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae and Flavobacterium columnare. Detection is carried out by means of monospecific antibodies of the IgY class, extracted and purified from the yolk of eggs of laying hens previously immunized with homologous bacterial antigens and applied in the immunochromatographic assay. BRIEF DESCRIPTION OF THE FIGURES

[11] FIG. 1A shows the diagnostic kit described in the present invention; 1B shows the functionality of said kit and 1C shows the interpretation of the results, where C = control and T = test.

[12] FIG. 2 shows a schematic representation of the block ELISA, where (A) is the sampling distribution in the 96-well plate. Y-axis: antigen concentrations, distributed in duplicate in wells 1, 2, 3 and 4 in rows A and B. X-axis: concentration of the detector antibody. Petition 870260077127, dated 03 / 08 / 2026, page 11 / 29 5 / 15 distributed in wells A, B, C, D, E, F, G and H, in column 1. (+) positive sample and (-) negative. (B) 96-well plate, showing the assay result, distribution same as plate (A). ABTS substrate, reading at 640 nm.

[13] FIG. 3 graphically presents the dynamics and evaluation of the production of specific IgY antibodies in the serum of laying hens immunized with membrane (A) and cytoplasmic (B) proteins of Lactococcus garvieae. The avidity index is expressed as a percentage (%) of specific membrane (C) and cytoplasmic (D) antibodies, evaluated in the serum pool (n=7) in the intervals between 0, 15, 30, 60, 90, 120 and 150 days after immunizations. Means (n=7) that have lowercase letters differ significantly between immunization intervals, according to Tukey's test (p>0.05).

[14] FIG. 4 graphically presents the dynamics and evaluation of the production of specific IgY antibodies in the serum of laying hens immunized with membrane (A) and cytoplasmic (B) proteins of Streptococcus agalactiae. The avidity index is expressed as a percentage (%) of specific membrane (C) and cytoplasmic (D) antibodies, evaluated in the serum pool (n=7) at intervals between 0, 15, 30, 60, 90, 120 and 150 days after immunizations. Means (n=7) that contain lowercase letters differ significantly between immunization intervals, according to Tukey's test (p>0.05).

[15] FIG. 5 graphically presents the dynamics and evaluation of the production of specific IgY antibodies in the serum of laying hens immunized with membrane (A) and cytoplasmic (B) proteins of Aeromonas hydrophila. The avidity index is expressed as a percentage (%) of Petition 870260077127, dated 03 / 08 / 2026, page 12 / 29 6 / 15 specific membrane (C) and cytoplasmic (D) antibodies, evaluated in the serum pool (n= 7) in the ranges between 0, 15, 30, 60, 90, 120 and 150 days after immunizations. Means (n=7) that have lowercase letters differ significantly between immunization intervals, according to Tukey's test (p>0.05).

[16] FIG. 6 graphically presents the dynamics and evaluation of the production of specific IgY antibodies in the serum of laying hens immunized with membrane (A) and cytoplasmic (B) proteins of Flavobacterium columnare. The avidity index is expressed as a percentage (%) of specific membrane (C) and cytoplasmic (D) antibodies, evaluated in the serum pool (n=7) at intervals between 0, 15, 30, 60, 90, 120 and 150 days after immunizations. Means (n=7) that contain lowercase letters differ significantly between immunization intervals, according to Tukey's test (p>0.05).

[17] FIG. 7 presents the Western blot technique for detecting the specificity of IgY for cellular proteins of Streptococcus agalactiae; Lactococcus garvieae; Aeromonas hydrophila and Flavobacterium columnare. Where: (A, C) SDS-PAGE gel (9% SDS) samples of total protein fractions applied in a volume of 30 pL per well, at a concentration of 7.7 pg. (P) Bio-Rad Precision Plus protein standard. (I) Samples of total bacterial cell fractions (cytoplasm and membrane). (B, E) Flavobacterium columnare and Aeromonas hydrophila respectively. 150-day pool serum, at a dilution of 1:1000.

[18] FIG. 8 shows the determination of the molecular mass of the protein from the purified yolk extract by gel electrophoresis (SDS-PAGE), where (P) Bio-Rad Precision Plus Standard, (1) IgY sample at a concentration of 40 Petition 870260077127, dated 03 / 08 / 2026, p. 13 / 29 7 / 15 pg.

[19] FIG. 9 graphically presents the test Block ELISA for determining the recognition potential of anti-Lactococcus garvieae IgY. The variables are IgY concentrations between 5, 10, 15, and 20 pg / mL, sequentially represented by the letters (A, B, C, and D), and its ability to recognize homologous concentrations of the membrane protein.

[20] FIG. 10 graphically presents the test Block ELISA for determining the recognition potential of anti-Lactococcus garvieae IgY. The variables are IgY concentrations between 5, 10, 15, and 20 pg / mL, sequentially represented by the letters (A, B, C, and D), and its ability to recognize homologous concentrations of the cytoplasmic protein.

[21] FIG. 11 graphically presents the test Block ELISA for determining the recognition potential of anti-Streptococcus agalactiae IgY. The variables are IgY concentrations between 5, 10, 15 and pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the membrane protein.

[22] FIG. 12 graphically presents the test Block ELISA for determining the recognition potential of anti-Streptococcus agalactiae IgY. The variables are IgY concentrations between 5, 10, 15 and pg / mL, sequentially represented by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the cytoplasmic protein.

[23] FIG. 13 graphically presents the test Block ELISA for determining the recognition potential of anti-Aeromonas hydrophila IgY. Having as Petition 870260077127, dated 03 / 08 / 2026, p. 14 / 29 8 / 15 variables the concentrations of IgY, between 5, 10, 15 and 20 pg / mL, represented sequentially by the letters (A, B, C and D) and their ability to recognize homologous concentrations of the membrane protein.

[24] FIG. 14 graphically presents the test Block ELISA for determining the recognition potential of anti-Aeromonas hydrophila IgY. The variables are IgY concentrations between 5, 10, 15, and 20 pg / mL, sequentially represented by the letters (A, B, C, and D), and its ability to recognize homologous concentrations of the cytoplasmic protein.

[25] FIG. 15 graphically presents the test Block ELISA for determining the recognition potential of anti-Flavobacterium columnare IgY. The variables are IgY concentrations between 5, 10, 15 and pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the membrane protein.

[26] FIG. 16 graphically presents the test Block ELISA for determining the recognition potential of anti-Flavobacterium columnare IgY. The variables are IgY concentrations, between 5, 10, 15 and pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the cytoplasmic protein.

[27] FIG. 17 presents the Dot blot block assay, schematizing the distribution of the samples. Y-axis: antigen concentrations. X-axis: detector antibody concentration. DAB developing substrate, reading on a Bio-Rad scanner and intensity volume (Int) analysis using Image Lab software (Bio-Rad);

[28] FIG. 18 graphically presents the test of Petition 870260077127, dated 03 / 08 / 2026, p. 15 / 29 9 / 15 Block dot blot for determining the recognition potential of anti-Lactococcus garvieae IgY. The variables are IgY concentrations, between 5, 10, 15 and 20 pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the membrane protein;

[29] FIG. 19 graphically presents the test of Block dot blot for determining the recognition potential of anti-Lactococcus garvieae IgY. The variables were IgY concentrations between 5, 10, 15, and 20 pg / mL, sequentially represented by the letters (A, B, C, and D), and its ability to recognize homologous concentrations of the cytoplasmic protein.

[30] FIG. 20 graphically presents the test of Block dot blot for determining the recognition potential of anti-Streptococcus agalactiae IgY. The variables are IgY concentrations, between 5, 10, 15 and pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the membrane protein.

[31] FIG. 21 graphically presents the test of Block dot blot for determining the recognition potential of anti-Streptococcus agalactiae IgY. The variables are IgY concentrations, between 5, 10, 15 and 20 pg / mL, represented sequentially by the letters (A, B, C and D), and its ability to recognize homologous concentrations of the cytoplasmic protein. DETAILED DESCRIPTION OF THE INVENTION

[32] The present invention relates to a multiple immunodiagnostic kit using lateral flow immunoassay, intended for the rapid and simultaneous detection of pathogens. Petition 870260077127, dated 03 / 08 / 2026, p. 16 / 29 10 / 15 bacteria in biological samples from fish in the context of fish farming. The kit comprises an integrated structure formed by two circular platforms, upper and lower, with a central region for sample application and distribution, in communication with immunochromatographic strips arranged in distinct detection channels. The platforms can be made of plastic material, for example, polyethylene terephthalate.

[33] The upper platform has windows for viewing the results, and the number of windows can be adjusted according to the number of tests applied. The upper platform also has a central hole for applying the sample.

[34] The lower platform is intended for the insertion of immunochromatographic strips. In the center of the circular area there is a hole for sample absorption, containing a high-absorption glass fiber element, in communication with the immunochromatographic strips, which receives and distributes the sample applied through the central hole, allowing each strip, containing specific biomarkers, to recognize the respective antigen or, in this context, the microbial pathogen.

[35] In one configuration, the kit comprises four nitrocellulose immunochromatographic strips, radially arranged in distinct detection channels, each strip intended for the specific detection of one of the following bacteria: Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae, and Flavobacterium columnare. The central well communicates with the strips via a glass fiber absorbent element, which promotes the distribution of the sample among the four strips and allows the simultaneous detection of the respective pathogens. FIGS. 1A, 1B, and 1C Petition 870260077127, dated 03 / 08 / 2026, p. 17 / 29 Pages 11 / 15 present, respectively, the structural details of the kit, its functionality, and the interpretation of the results.

[36] Detection is performed using monospecific IgY class antibodies, extracted and purified from the yolk of eggs of previously immunized laying hens and specific for the bacterial antigens of the described pathogens. Each immunochromatographic strip comprises a conjugation region containing IgY antibodies conjugated to silver nanoparticles approximately 40 nm in diameter, adsorbed onto glass fiber and used as initial detector molecules. Each strip also comprises a test region, formed by a nitrocellulose membrane containing specific unconjugated IgY antibodies. During sample migration, the antigen bound to the conjugated IgY is captured by the immobilized IgY in the test region, forming a sandwich-type immune complex and producing a visible band indicative of a positive result.

[37] A third antibody of the monospecific IgG class, produced in rabbits and specific for the constant fraction (Fc) of IgY, is applied to the nitrocellulose membrane representing the third phase. Its function is to validate the tests by verifying the migration of biomolecules through the nitrocellulose fiber, immobilizing IgY not bound to the antigen, proving the flow of this molecule. It is, therefore, the positive control of the test. The revelation of the test line (6) and control line (7) confirms the positivity of the sample. EXAMPLE OF IMPROVING THE INVENTION Evaluation of serum production of IgY antibodies against Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae, and Flavobacterium columnare. Petition 870260077127, dated 03 / 08 / 2026, page 18 / 29 12 / 15

[38] During the immunization protocol, the birds' serum was collected and tested for positive reactivity to antigenic epitopes, constituents of the membrane and cytoplasmic proteins of the aforementioned bacteria. However, before performing the enzyme-linked immunosorbent assay (ELISA) to evaluate the humoral immune response, a block assay was previously performed to determine the ideal concentration between antibody and antigen, varying the antigen concentrations in relation to the serum dilution of the immunized birds. The serum pool used was that of 150 days after the start of the immunization protocol. Four serum dilutions were tested; 1:10, 1:100, 1:1000 and 1:10,000. The concentrations of both proteins (cytoplasmic or membrane) tested were respectively; 5, 10, 15 and 20 (pg / ml).The best ratio between serum dilution and antigen concentration for all samples tested was 1:100, with 10 (pg / ml) representing the equivalence zone. A schematic representation of the block ELISA is illustrated in FIG. 2.

[39] The igY produced showed specificity for antigenic epitopes in cytoplasmic and membrane proteins, present in all microorganisms tested. They became detectable on the 15th day after the first inoculation of the antigen. With a significant increase, varying between 120 and 150 days of the immunization protocol for both bacterial proteins. Concomitantly, a progressive increase in avidity potential between the same days was also observed, for both antigens and group of bacteria. Therefore, the pattern of the humoral immune response of the birds was similar for all bacteria tested, as can be seen in FIGS. 3, 4, 5 and 6. Western blot for IgY specificity analysis Petition 870260077127, dated 03 / 08 / 2026, page 19 / 29 13 / 15

[41]

[40] IgY showed specificity for several protein bands present in the bacterial extracts tested. Subsequently identified through molecular mass as proteins constituting the cell wall, membrane and cytoplasm, as pre-formed exotoxins in the transient vesicular phase. Therefore, the IgY produced individually for each bacterial antigen were able to distinguish and recognize both the bacterial cell and its exotoxins released during the course of infection. The immunolabeled protein bands for each protein fraction and bacterial cell are shown in FIG. 7. IgY Purification The 150-day pool of egg yolk from immunized birds was purified and analyzed by SDS gel electrophoresis. Two bands were observed, the first with an approximate molecular weight of 84 kDa and the second with a weight of 28 kDa (FIG 8). The results for the molecular weight, location, and intensity of expression of these two bands are similar to the molecular structure of IgY, which consists of a heavy chain and a light chain, thus confirming the presence of immunoglobulin in the purified extract. Validation and determination of the sensitivity of the IgY test in vitro.

[42] The sensitivity potential of IgY for the detection of the respective bacterial antigens was validated through two assays, ELISA and Dot blot, both in block, with antigen and antibody concentrations between 5, 10, 15 and 20 (pg / ml) as variables. The ELISA results are shown in FIGS 9 to 16, and the Dot blot results in FIGS 17 to 21. Petition 870260077127, dated 03 / 08 / 2026, page 20 / 29 14 / 15

[45]

[43] The tested IgY concentrations were reactive for all antigen concentrations, with the detection potential increasing exponentially and relative to the increase in IgY concentration. However, the degree of sensitivity demonstrated that 5 pg of IgY are capable of detecting 5, 10, 15 and 20 (pg / ml) of bacterial membrane and cytoplasmic proteins.

[44] When these values ​​are corrected for the volumes used for each assay, it is concluded that in the ELISA assay, 5 ng of IgY were able to detect 5 ng of bacterial proteins. In the dot blot assay, 5 pg of IgY in a 10 mL volume of buffer was able to detect 5, 10, 15 and (ng / pL) of the two protein fractions. The distribution of samples in the dot blot assay is shown in FIG 10 and the results for the two tests, which were similar, are shown in FIGS. 9 to 16. Application of IgY for the immunochromatographic test

[46] After quantitative and qualitative analyses, pg of IgY were conjugated to 1 mL of colloidal silver nanoparticle suspension approximately 40 nm in diameter. The conjugated IgY antibodies were adsorbed onto glass fiber in the conjugation region of the immunochromatographic strip. Subsequently, IgY antibodies specific for homologous antigens, not conjugated to silver nanoparticles, were immobilized on the nitrocellulose membrane, forming the test region intended for the capture of the antigen-conjugated IgY complex. A third antibody, of the IgG class and specific for the Fc fragment of IgY, was immobilized in the control region to capture the conjugated IgY not bound to the antigen, confirming the migration of the molecules and the functioning of the test. Petition 870260077127, dated 03 / 08 / 2026, page 21 / 29 15 / 15

[47] To determine the sensitivity of the test, different concentrations of the bacterial membrane / cytoplasm antigen were analyzed between 5, 10, 15 and (μg / mL), and 100 μl of the sample, being adsorbed for each test, concentration and species of bacterial cell. The concentrations of the molecules coupled to the chromatographic strip were previously standardized and kept unchanged, varying only the concentrations of the antigen.

[48] ​​The test has the potential to detect and distinguish microbial proteins from each species and genus of bacteria studied, in addition to sensitivity for detecting between 5, 10, 15 and 20 (μg / mL) of bacterial proteins.

[49] Although the invention has been extensively described, it is obvious to those skilled in the art that various alterations and modifications can be made with a view to improving the design without such alterations not being covered by the scope of the invention. Petition 870260077127, dated 03 / 08 / 2026, page 22 / 29

Claims

1 / 3 CLAIMS 1. Multiple immunodiagnostic kit using lateral flow immunoassay, intended for the rapid and simultaneous detection of bacterial pathogens in biological samples of fish in the context of fish farming, characterized by comprising an integrated structure formed by two circular platforms, upper and lower, equipped with a central region for application and distribution of the sample in fluidic communication with a plurality of nitrocellulose immunochromatographic strips arranged radially in distinct detection channels, the platform being configurable to accommodate different numbers of immunochromatographic strips and respective viewing windows, according to the number of targets to be detected, comprising, in one configuration, four strips intended for the specific detection of Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae and Flavobacterium columnare,wherein each strip comprises a conjugation region containing monospecific IgY class antibodies conjugated to silver nanoparticles and a test region containing unconjugated monospecific IgY class antibodies, said IgY antibodies being extracted and purified from the yolk of laying hen eggs.

2. Kit, according to claim 1, characterized in that the upper platform has windows for viewing the results, so that the quantity / number of windows can be readjusted to the number of tests to be applied, and also a central hole for sample adsorption.

3. Kit, according to claim 1, characterized by the fact that the lower platform has inserted in the center of its circular area a quadrant of high-absorption fiberglass.

4. Kit, according to claim 3, characterized in that the quadrant interconnects and promotes the absorption of the sample for the four chromatographic strips, allowing each strip, with specific biomarkers, to recognize the specific molecule or pathogen.

5. Kit, according to any one of claims 1 to 4, characterized in that the central hole connects the strips through an absorbent filter paper that links the four immunochromatographic strips, and allows sample adsorption and simultaneous pathogen detection.

6. Use of the kit, as defined in the preceding claims, characterized by the fact that it allows the simultaneous detection, in a single sampling, of specific bacterial antigens of the pathogens Aeromonas hydrophila, Streptococcus agalactiae, Lactococcus garvieae and Flavobacterium columnare, comprising antigenic components associated with the bacterial cell wall and exotoxins produced by said pathogens.

7. Use, according to claim 6, characterized in that the detection utilizes monospecific antibodies of the IgY class, extracted and purified from the yolk of laying hens, and specific for bacterial antigens of said bacteria.

8. Use according to claim 7, characterized in that the IgY are used in two phases, the first conjugated with silver nanoparticles of approximately 40 nm in diameter, and the second not conjugated with silver.

9. Use, according to claim 8, Petition 870260077127, dated 03 / 08 / 2026, page 24 / 29 3 / 3 characterized by the fact that in the first phase IgY is adsorbed onto the glass fiber, in the first phase of the chromatographic strip, as the initial detector molecule.

10. Use, according to claim 8, characterized by the fact that in the second phase the IgY is adsorbed onto the nitrocellulose membrane and detects the antigen bound to the antibody, forming a sandwich complex, paralyzing the antigen neutralized with the IgY conjugate from the first phase during migration, revealing a gray band, thus partially making the test positive.

11. Use, according to any one of claims 6 to 10, characterized in that a third monospecific IgG class antibody produced in rabbits and specific for the constant fraction (Fc) of IgY is applied to the nitrocellulose membrane representing the third phase.

12. Use, according to claim 11, characterized by the fact that the IgG antibody validates the tests by verifying the migration of biomolecules through the nitrocellulose fiber, immobilizing IgY not bound to the antigen, proving the flow of this molecule. Petition 870260077127, dated 03 / 08 / 2026, pp. 25 / 29